An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough

Blocking NMDA receptors with memantine in refractory chronic cough patients is poorly tolerated and demonstrates no improvement in cough https://bit.ly/3kgx2g1

Detalles Bibliográficos
Autores principales: Abdulqawi, Rayid, Satia, Imran, Holt, Kimberley J., Dockry, Rachel, Sen, Shilpi, Smith, Jaclyn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450582/
https://www.ncbi.nlm.nih.gov/pubmed/34549048
http://dx.doi.org/10.1183/23120541.00447-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450582/
https://www.ncbi.nlm.nih.gov/pubmed/34549048
http://dx.doi.org/10.1183/23120541.00447-2021

Ejemplares similares